Morgan Stanley
SONM icon

Morgan Stanley’s DNA X Inc SONM Stock Holding History

Morgan Stanley’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17
Closed -$181 – 8434
2025
Q3 		$181 Hold
17
– – ﹤0.01% 7611
2025
Q2 		$366 Buy
+17
New +$419 ﹤0.01% 7492
2022
Q4 		– Hold
0
– – – 7953
2022
Q3 		– Sell
-59
Closed -$7.33K – 7858
2022
Q2 		$6K Buy
59
+51
+638% +$5.76K ﹤0.01% 7368
2022
Q1 		$1K Sell
8
-7,205
-100% -$976K ﹤0.01% 7865
2021
Q4 		$1.2M Buy
7,213
+6,949
+2,632% +$2.11M ﹤0.01% 4943
2021
Q3 		$128K Buy
264
+248
+1,550% +$188K ﹤0.01% 6225
2021
Q2 		$16K Buy
+16
New +$17.4K ﹤0.01% 7078
2021
Q1 		– Sell
-1
Closed -$1.76K – 7552
2020
Q4 		$1K Hold
1
– – ﹤0.01% 6969
2020
Q3 		$2K Sell
1
-2
-67% -$3.21K ﹤0.01% 6589
2020
Q2 		$4K Buy
3
+1
+50% +$1.6K ﹤0.01% 6353
2020
Q1 		$3K Sell
2
-5
-71% -$24K ﹤0.01% 6338
2019
Q4 		$48K Buy
7
+6
+600% +$29.6K ﹤0.01% 5871
2019
Q3 		$4K Buy
+1
New +$15.3K ﹤0.01% 6403
2019
Q2 		– Hold
0
– – – 6197

Other funds holding SONM

PCM
Potomac Capital Management New York $115M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley's SONM Position: Q4 2025 in Review

Morgan Stanley sold out of DNA X Inc (SONM) in Q4 2025, closing a stake of 17 shares — an estimated $181 sold.

Morgan Stanley first reported a position in SONM in Q3 2019 and held it in 13 quarters. The position peaked at $1.2M in Q4 2021. 8 funds tracked by Wall St. Rank hold SONM as of Q4 2025.

  • Morgan Stanley reported no remaining DNA X Inc position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 17 DNA X Inc shares in Q4 2025, an estimated $181.
  • Morgan Stanley first reported a position in DNA X Inc in Q3 2019 and held it in 13 quarters.
  • Morgan Stanley's DNA X Inc position peaked at $1.2M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.